Basisstatistiken
| LEI | 529900DHF2OCON457Y71 |
| CIK | 1656472 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cronos Group Inc.
SEC Filings (Chronological Order)
Auf dieser Seite finden Sie eine vollständige, chronologische Liste der SEC-Einreichungen, mit Ausnahme der Eigentumseinreichungen, die wir an anderer Stelle bereitstellen.
| May 29, 2026 |
CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2025 Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2025 Overview: Cronos Group Inc. is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. References to “Cronos” in this report ref |
|
| May 29, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 4491 Concession Rd 12 Stayner, Ontario L0M 1S0 (Address of princi |
|
| May 11, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 11, 2026 |
Exhibit 10.3 October 31, 2025 Adam Wagner At the Address on file with the Company Dear Adam, Further to our recent discussions, this letter is to confirm that, effective as of October 30, 2025, your position title will be General Manager, Cronos Israel. All other all terms and conditions of your employment, as set forth in your employment agreement with Cronos Israel G.S. Cultivation Ltd. and Cron |
|
| May 11, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2026 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 11, 2026 |
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) Exhibit 10.1 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS ISRAEL G.S. CULTIVATION LTD. (No. 515790988) (the “Company”) - and - ADAM WAGNER, Israeli ID number 066080755 an individual residing in the City of Pardes Hanna Karkur, in Israel (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Compan |
|
| May 11, 2026 |
DATED 8 MAY 2026 CGM B.V. as the Purchaser and CRONOS GROUP INC. as the Guarantor and "RING" INTERNATIONAL HOLDING AG LANDEWYCK TOBACCO S.A. as the Sellers AGREEMENT TO AMEND THE SHARE PURCHASE AGREEMENT DATED 9 DECEMBER 2025 THIS AMENDMENT AGREEMENT IS MADE ON 8 MAY 2026, BETWEEN (1)CGM B.V., a company incorporated under the laws of the Netherlands with its corporate seat in Amsterdam, the Nether |
|
| May 11, 2026 |
Cronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45. |
|
| May 11, 2026 |
Exhibit 10.2 May 6, 2025 Adam Wagner At the Address on file with the Company Dear Adam, This letter agreement (this “Letter Agreement”), effective as of May 6, 2025 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding changes to your compensation. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in your employ |
|
| April 24, 2026 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 24, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| February 26, 2026 |
Exhibit 10.31 February 24, 2026 Shannon Buggy At the Address on file with the Company Dear Shannon, This letter agreement (this “Letter Agreement”), effective as of February 24, 2026 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Senior Vice President, Global Head of People. Capitalized terms used in this Letter Agreement that are not de |
|
| February 26, 2026 |
FIRST AMENDMENT TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.16 FIRST AMENDMENT TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is entered into this February 25, 2026 between CRONOS USA CLIENT SERVICES LLC, a limited liability company incorporated in the State of Delaware (the “Company”) and MICHAEL GORENSTEIN, an individual resident in Miami Bea |
|
| February 26, 2026 |
Exhibit 10.3 TERMINATION AGREEMENT This TERMINATION AGREEMENT (this “Agreement”) is made as of December 15, 2025 (the “Termination Effective Date”), by and between Ginkgo Bioworks, Inc., a corporation duly organized and existing under the laws of the State of Delaware, U.S.A. (“Ginkgo”) and Cronos Group Inc., a corporation duly organized and existing under the laws of the Province of British Colum |
|
| February 26, 2026 |
Exhibit 10.21 November 8, 2024 Mr. Jeffrey Jacobson At the Address on file with the Company Dear Jeff, Further to our recent discussions, this letter is to confirm that, effective as of October 24, 2024, the Base Salary, as defined in your amended and restated employment agreement with Cronos USA Client Services LLC and, solely for the purposes specified therein, Cronos Group Inc. and Hortican Inc |
|
| February 26, 2026 |
SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2025 Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2025 Subsidiaries State or other jurisdiction of incorporation or organization Cronos Growing Company Inc. Canada Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. Israel Cronos Israel G.S. Pharmacy Ltd. Israel Cronos Isra |
|
| February 26, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 26, 2026 |
Exhibit 99.1 Cronos Group Reports 2025 Fourth Quarter and Full-Year Results Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025 Eighth consecutive quarter of record net revenue in Israel, where PEACE NATURALS® continues to be the number one cannabis brand |
|
| February 26, 2026 |
Exhibit 10.26 February 24, 2026 Anna Shlimak At the Address on file with the Company Dear Anna, This letter agreement (this “Letter Agreement”), effective as of February 24, 2026 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding changes to your compensation. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth |
|
| February 26, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| December 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| December 9, 2025 |
Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67. |
|
| December 9, 2025 |
Exhibit 2.1 DATED 9 DECEMBER 2025 CGM B.V. as the Purchaser and CRONOS GROUP INC. as the Guarantor and "RING" INTERNATIONAL HOLDING AG LANDEWYCK TOBACCO S.A. as the Sellers SHARE SALE AND PURCHASE AGREEMENT WITH RESPECT TO THE SHARES IN CANADELAAR B.V. Exhibit 2.1 TABLE OF CONTENTS Exhibit 2.1 Clause Headings Page 1. INTERPRETATION 2 2. SALE AND PURCHASE 3 3. CONSIDERATION 3 3.1 Initial Purchase P |
|
| November 6, 2025 |
Exhibit 99.1 Cronos Group Reports 2025 Third Quarter Results Achieved record levels of consolidated net revenue, gross profit and Adjusted EBITDA Net revenue in Q3 2025 increased by 9% quarter-over-quarter and 6% year-over-year Generated record-high net revenue in Israel, where PEACE NATURALS® remains the number one cannabis brand1 Industry-leading balance sheet with $824 million in total cash and |
|
| November 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employ |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 7, 2025 |
Exhibit 99.1 Cronos Group Reports 2025 Second Quarter Results Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug |
|
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 4491 Concession Rd 12 Stayner, Ontario L0M 1S0 (Address of princi |
|
| June 2, 2025 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group Inc. and i |
|
| May 8, 2025 |
Exhibit 99.1 Cronos Group Reports 2025 First Quarter Results Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in total cash and cash equivalents and short-term investments TORONTO, May 8, 2025 - |
|
| May 8, 2025 |
Letter Agreement by and among Shannon Buggy, Cronos USA and the Company, dated May 6, 2025. Exhibit 10.3 May 6, 2025 Shannon Buggy At the Address on file with the Company Dear Shannon, This letter agreement (this “Letter Agreement”), effective as of May 6, 2025 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Senior Vice President, Global Head of People and Technology. Capitalized terms used in this Letter Agreement that are not |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 8, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| April 25, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| March 19, 2025 |
EXHIBIT 10.1 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - ANNA SHLIMAK (the “Executive”) - and - solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Cronos Group; WHEREAS the Executive is currently employed by the Company pursuant to |
|
| March 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| March 19, 2025 |
EXHIBIT 10.2 March 19, 2025 James Holm At the Address on file with the Company Dear James, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your resignation from your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 27, 2025 |
Exhibit 10.22 November 8, 2024 Mr. Jeffrey Jacobson At the Address on file with the Company Dear Jeff, Further to our recent discussions, this letter is to confirm that, effective as of October 24, 2024, the Base Salary, as defined in your amended and restated employment agreement with Cronos USA Client Services LLC and, solely for the purposes specified therein, Cronos Group Inc. and Hortican Inc |
|
| February 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 27, 2025 |
Exhibit 99.1 Cronos Group Reports 2024 Fourth Quarter and Full-Year Results Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million Spinach® Ends 2024 as the Number One Cannabis Brand in Canada1 PEACE NATURALS® Ends 2024 as the Number One Cannabis Brand in Israel 2 Industry leading balance sheet with $859 mil |
|
| February 27, 2025 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2024 Subsidiaries State or other jurisdiction of incorporation or organization Cronos Growing Company Inc. Canada Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. Israel Cronos Israel G.S. Pharmacy Ltd. Israel Cronos Isra |
|
| February 27, 2025 |
Cronos Group Insider Trading Policy Exhibit 19.1 Insider Trading Policy Cronos Group Inc. Effective as of January 1, 2020 Version 2025A TABLE OF CONTENTS Section 1: Policy Overview 3 General Matters 4 Violations of Policy and Disciplinary Action 5 Scope 7 Section 2: Prohibited Conduct 9 Prohibition on Insider Trading 10 Prohibition Against Speculation, Hedging and Short-Selling 15 Prohibition on Pledging of Securities 16 No Standing |
|
| November 12, 2024 |
Certificate of Continuance and Articles of Cronos Group Inc. Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE Certificate of Continuation Number C1256453 ARTICLES OF Cronos Group Inc |
|
| November 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 12, 2024 |
Exhibit 10.1 August 23, 2024 Anna Shlimak At the Address on file with the Company Dear Anna, This letter agreement (this “Letter Agreement”), effective as of August 23, 2024 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Chief Strategy Officer. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings |
|
| November 12, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 Third Quarter Results Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million Spinach® Becomes the Number One Cannabis Brand in Canada1 Industry-leading balance sheet with $862 million in cash and cash equivalents TORONTO, November 12, 2024 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2024 thir |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| August 8, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 8, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 Second Quarter Results Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 million Industry-leading balance sheet with $848 million in cash and cash equivalents Announced expansion of Cronos GrowCo designed to fuel global growth TORONTO, August 8, 2024 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced its 2 |
|
| August 8, 2024 |
Certificate of Continuance and Articles of Cronos Group Inc. Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE Certificate of Continuation Number C1256453 ARTICLES OF Cronos Group Inc |
|
| July 22, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employ |
|
| July 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 25, 2024 |
Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*** - Commercially Sensitive Information Redacted], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED CREDIT AGREEMENT dated as of June 20, 2024 among CRONOS GROWING COMPANY INC. as Borrower and THE LENDERS FROM TIM |
|
| June 25, 2024 |
Exhibit 10.2 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*** - Commercially Sensitive Information Redacted], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED SUPPLY AGREEMENT between CRONOS GROWING COMPANY INC. and PEACE NATURALS PROJECT INC. dated as of JUNE 20, 2024 AM |
|
| June 21, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 28, 2024 |
Cronos Terminates Sale-Leaseback of Peace Naturals Campus Cronos Terminates Sale-Leaseback of Peace Naturals Campus TORONTO, May 28, 2024 (GLOBE NEWSWIRE) – Cronos Group Inc. |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| May 15, 2024 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2023 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group Inc. and i |
|
| May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 9, 2024 |
Exhibit 99.1 Cronos Group Reports 2024 First Quarter Results Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach® was top-3 in retail sales in Canada in the flower, edible, and vape categories in Q1 2024 Launched PEACE NATURALS® brand in the United Kingdom in May 2024 TORONTO, May 9, 2024 - Cr |
|
| May 9, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 26, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 25, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| April 25, 2024 |
EXECUTION VERSION 4855-8885-6758 v.7 VOTING AGREEMENT This VOTING AGREEMENT (this “Agreement”), dated as of April 24, 2024, is entered into by and between Cronos Group Inc., a corporation organized under the Laws of the Province of British Columbia, Canada (the “Company”), and Altria Group, Inc., a Virginia corporation (the “Shareholder” and, together with the Company, each a “Party” and collectiv |
|
| April 25, 2024 |
CRON / Cronos Group Inc. / ALTRIA GROUP, INC. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Cronos Group Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 22717L101 (CUSIP Number) W. Hildebrandt Surgner, Jr. Vice President, Corporate Secretary and Associate General Counsel Altria Group, Inc. 6601 West Broa |
|
| April 17, 2024 |
Letter from KPMG LLP to the Securities and Exchange Commission dated April 16, 2024 KPMG LLP Vaughan Metropolitan Centre 100 New Park Place Suite 1400 Vaughan, ON, L4K 0J3 Telephone (905) 265-5900 Fax (905) 265-6390 www. |
|
| April 17, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2024 (April 11, 2024) CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commissio |
|
| April 3, 2024 |
a240401gorelikemployment EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS ISRAEL G. |
|
| April 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 1, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| February 29, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 29, 2024 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2023 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. |
|
| February 29, 2024 |
Exhibit 10.30 AMENDING AGREEMENT THIS AGREEMENT is made as of February 8, 2024, BETWEEN: PEACE NATURALS PROJECT INC. (the “Seller”) - and - FUTURE FARMCO CANADA INC. (the “Buyer”) RECITALS: A.Pursuant to an agreement of purchase and sale (commercial) dated as of November 26, 2023, between the Seller and the Buyer (as amended to the date hereof, collectively, the “Purchase Agreement”), the Seller a |
|
| February 29, 2024 |
Exhibit 99.1 Cronos Group Reports 2023 Fourth Quarter and Full-Year Results1 Ended 2023 with approximately $862 million in cash and short-term investments Commenced sales to Australian partner Launched award-winning Lord Jones® brand in Canada Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022; on a constant currency basis consolidated net revenue increased 11% in Q4 2023 compare |
|
| February 29, 2024 |
Exhibit 97.1 Restatement Compensation Recovery Policy Cronos Group Inc. Effective as of December 1, 2023 Department: Finance Policy Owner: Chief Financial Officer Policy Validator: Compensation Committee of the Board of Directors For updates or additions, please contact [email protected]. This document is uncontrolled when printed. For the current, official copy of this policy |
|
| February 29, 2024 |
Exhibit 10.24 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - JEFF JACOBSON (the “Executive”) - and - solely for the purposes specified herein, HORTICAN INC. (“Hortican”) - and - solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Crono |
|
| February 29, 2024 |
ce Naturals Project Inc. and Future Farmco Canada In Exhibit 10.31 WAIVER AND AMENDING AGREEMENT THIS AGREEMENT is made as of February 29, 2024, BETWEEN: PEACE NATURALS PROJECT INC. (the “Seller”) - and - FUTURE FARMCO CANADA INC. (the “Buyer”) RECITALS: A.Pursuant to an agreement of purchase and sale (commercial) dated as of November 26, 2023, between the Seller and the Buyer (as amended to the date hereof, collectively, the “Purchase Agreement”), |
|
| February 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| November 27, 2023 | ||
| November 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 27, 2023 |
Cronos Group Inc. enters into agreement for the sale-leaseback of its Stayner, Ontario facility TORONTO, November 27, 2023 (GLOBE NEWSWIRE) – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that its wholly owned subsidiary entered into an agreement (the “Sale Agreement”) with Future Farmco Canada Inc. (the “Buyer”), a vertical farming company, for the sale |
|
| November 8, 2023 |
Exhibit 99.1 Cronos Group Reports 2023 Third Quarter Results Industry-leading balance sheet with $840 million in cash and short-term investments Net revenue in Q3 2023 increased by 22% year-over-year to $24.8 million; on a constant currency basis, net revenue in Q3 2023 increased by 27% year-over-year to $26.0 million Spinach® was top-10 in retail sales in Canada in every category it's in - flower |
|
| November 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| August 8, 2023 |
Exhibit 99.1 Cronos Group Reports 2023 Second Quarter Results Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to streamline supply chain and improve cash flow Spinach® was top-10 in retail sales in every category it participates in - flower, edible, vape and pr |
|
| August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 23, 2023 |
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders TORONTO, June 23, 2023 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023 (the “Meeting”), shareholders holding a total of 247,410,987 common shares of the Company voted in person or by proxy, represen |
|
| May 31, 2023 |
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow Plans to Exit Existing U. |
|
| May 31, 2023 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2022 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. References to “Cronos” in this report refer to Cronos Group In |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 18, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 9, 2023 |
ex991 Exhibit 99.1 Cronos Group Reports 2023 First Quarter Results Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compared to Q1 2022; on a constant currency basis net revenue in Canada increased 14% in Q1 2023 compared to Q1 2022 Spinach® was top-10 in retail sales in the flower |
|
| May 9, 2023 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement") BETWEEN: HORTICAN INC. (the "Company") -and - Jeff Jacobson (the "Executive") -and - solely for the purposes specified herein, CRONOS GROUP INC. ("Cronos Group") WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to continue to engage the services of the Executive in a senior and specialized ca |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy St |
|
| April 28, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D |
|
| February 28, 2023 |
Letter Agreement by and between Anna Shlimak and Cronos USA Client Services LLC, dated February Exhibit 10.32 February 21, 2023 Anna Shlimak At the Address on file with the Company Dear Anna, Further to our recent discussions, this letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), confirms the following amendment to your employment agreement with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware |
|
| February 28, 2023 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2022 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel Cronos Israel G.S. Cultivation Ltd. |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 28, 2023 |
ex991-cron4q22earningspr Cronos Group Reports 2022 Fourth Quarter and Full-Year Results Consolidated net revenue increased 23% in Full Year 2022 compared to Full Year 2021; on a constant currency basis consolidated net revenue increased 28% in Full Year 2022 compared to Full Year 2021 Net revenue in Israel increased 128% in Full Year 2022 compared to Full Year 2021; on a constant currency basis net revenue in Israel increased 137% in Full Year 2022 compared to Full Year 2021 Ended 2022 with $878 million in cash and short-term investments Spinach® became the number one edible brand in Canada in January 2023 TORONTO, February 28, 2023 - Cronos Group Inc. |
|
| February 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 13, 2023 |
ex101-madoreletteragreem EXECUTION VERSION February 8, 2023 Robert Madore At the Address on file with the Company Dear Bob, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your separation from employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the “Company”) and wholly owned subsidiary of Cronos Group Inc. |
|
| February 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commi |
|
| December 19, 2022 |
warrantlettercronos002 |
|
| December 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| December 19, 2022 |
EX-99.4 Exhibit 99.4 Altria Summit LLC 6601 West Broad Street Richmond, Virginia 23230 December 16, 2022 Cronos Group Inc. 720 King Street West Suite 320 Toronto, ON M5V 2T3 Attention: General Counsel Telephone: (416) 504-0004 Email: [email protected] Re: Abandonment of Warrant Issued by Cronos Group Inc. Dear Ladies and Gentlemen: Altria Summit LLC, the holder of a warrant to purchase 84,0 |
|
| December 19, 2022 |
CRON / Cronos Group Inc. / ALTRIA GROUP, INC. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Cronos Group Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 22717L101 (CUSIP Number) W. Hildebrandt Surgner, Jr. Vice President, Corporate Secretary and Associate General Counsel Altria Group, Inc. 6601 West Broa |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 14, 2022 |
ex101-holmemploymentagre EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - JAMES HOLM (the “Executive”) - and - solely for the purposes specified herein, CRONOS GROUP INC. |
|
| November 7, 2022 |
Exhibit 10.1 November 7, 2022 Jeff Jacobson At the Address on file with the Company Dear Jeff, This letter agreement (this “Letter Agreement”), effective as of November 7, 2022 (the “Effective Date”), sets forth the terms and conditions of our agreement regarding your new position as Chief Growth Officer. Capitalized terms used in this Letter Agreement that are not defined herein have the meanings |
|
| November 7, 2022 |
ex991toq3earnings8-k Cronos Group Reports 2022 Third Quarter Results Reported consolidated net revenue increased 3% year-over-year to $20. |
|
| November 7, 2022 |
Exhibit 10.2 November 7, 2022 John Griese At the Address on file with the Company Dear John, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of our agreement regarding the separation of your employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (“ |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| October 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| October 25, 2022 |
exhibit101 UNITED STATES OF AMERICA Before the SECURITIES AND EXCHANGE COMMISSION SECURITIES ACT OF 1933 Release No. |
|
| October 25, 2022 |
exhibit102 Ontario Commission des 22nd Floor 22e étage Securities valeurs mobilières 20 Queen Street West 20, rue queen ouest Commission de l’Ontario Toronto ON M5H 3S8 Toronto ON M5H 3S8 IN THE MATTER OF CRONOS GROUP INC. |
|
| October 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 9, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 9, 2022 |
Exhibit 99.1 Cronos Group Reports 2022 Second Quarter Results Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net revenue increased by 212% year-over-year to $7.2 million in Q2 2022 Announced achievement of THCV equity milestone TORONTO, August 9, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos? or the ?Company?), today announces its 2022 se |
|
| August 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| June 24, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 24, 2022 |
Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders TORONTO, June 24, 2022 (GLOBE NEWSWIRE) - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos? or the ?Company?) announces that at its Annual Meeting of Shareholders held on June 23, 2022 (the ?Meeting?) shareholders voting in person or by proxy held in total 265,763,587 common shares of the Company, representing 70.76% o |
|
| May 31, 2022 |
SD 1 formsd123121.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ont |
|
| May 31, 2022 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2021 Overview: Cronos Group Inc. is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. References to ?Cronos? in this report refer to Cronos Group In |
|
| May 10, 2022 |
Exhibit 99.1 Cronos Group Reports 2022 First Quarter Results Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net revenue increased by 263% year-over-year to $9.1 million in Q1 2022 Increased market share in Canada and Israel in Q1 2022 Mike Gorenstein returned as Chief Executive Officer TORONTO, May 10, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) |
|
| May 10, 2022 |
Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS ISRAEL G.S. CULTIVATION LTD. (No. 515790988) (the ?Company?) - and - RAN GORELIK, Israeli ID number 56789472, an individual residing in the City of Shilat, in Israel (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is an indirectly wholly-owned su |
|
| May 10, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| May 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| April 29, 2022 |
DEF 14A 1 a2022drafproxystatement.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use o |
|
| April 29, 2022 |
DEFA14A 1 a2022defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| March 21, 2022 |
EXECUTION VERSION AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN: CRONOS USA CLIENT SERVICES LLC a limited liability company incorporated in the State of Delaware (the ?Company?) - and - MICHAEL GORENSTEIN an individual resident in Miami Beach, in the State of Florida (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| March 21, 2022 |
EXECUTION VERSION March 21, 2022 Kurt Schmidt At the Address on file with the Company Dear Kurt, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your retirement from employment with Cronos USA Client Services LLC, a limited liability company incorporated in the State of Delaware (the ?Company?) and wholly owned subsidiary of Cronos Group Inc. |
|
| March 21, 2022 |
Cronos Group Founder Mike Gorenstein Returns as CEO Kurt Schmidt, President and Chief Executive Officer, to Retire TORONTO, March 21, 2022 (GLOBE NEWSWIRE) ? Cronos Group Inc. |
|
| March 1, 2022 |
Description of Capital Stock of Cronos Group Inc. Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following description of the capital stock of Cronos Group Inc. (the ?Company,? ?we,? ?us,? and ?our?) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Continuation, Notice of Articles and Articles (the ?Art |
|
| March 1, 2022 |
Exhibit 99.1 Cronos Group Reports 2021 Fourth Quarter and Full-Year Results Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020 Announces the planned exit of its Peace Naturals Campus in Stayner, Ontario to streamline supply chain and improve profitability TORONTO, March 1, 2022 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group? or the ?Company?), today |
|
| March 1, 2022 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2021 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Malta Holdings Limited Malta Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel |
|
| March 1, 2022 |
Exhibit 10.28 EXECUTION VERSION February 17, 2022 Anna Shlimak At the Address on file with the Company Dear Anna, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your position as Senior Vice President, Corporate Affairs. Capitalized terms used in this Letter Agreement that are no |
|
| March 1, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| March 1, 2022 |
Exhibit 10.27 EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) ?and - JOHN GRIESE (the ?Executive?) ?and - solely for the purposes specified herein, CRONOS GROUP INC. (the ?Cronos Group?) - and ? solely for the purposes specified herein, HORTICAN INC. (?Hortican?) WHEREAS the Company is a wholly-owned subsidiary of Cronos G |
|
| March 1, 2022 |
Exhibit 14.1 Code of Business Conduct and Ethics Cronos Group Inc. Effective as of November 1, 2018 Department: Legal Policy Owner: Xiuming Shum, General Counsel Policy Validator: Board of Directors of Cronos Group Inc. For updates or additions, please contact the Legal Department at [email protected] This document is uncontrolled when printed. For the current, official copy o |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001- |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| February 18, 2022 |
Exhibit 99.1 Cronos Group Reports 2021 Third Quarter Results Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment to support future growth strategies Consolidated net revenue increased 80% in the third quarter of 2021 compared to the third quarter of 2020 Launched Cronos Group's first cultured cannabinoid gummy and vape pr |
|
| February 18, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 18, 2022 |
NT 10-Q/A 1 cronos12b-251.htm NT 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A NOTIFICATION OF LATE FILING Commission File Number: 001-38403 CUSIP: 22717L1013 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Fo |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 30, 2021 |
Letter Agreement, dated as of November 26, 2021, between Hortican November 26, 2021 Xiuming Shum At the Address on file with the Company Dear Xiuming, This letter agreement (this ?Letter Agreement?), effective as of the date hereof (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding your resignation from your employment with Hortican Inc. |
|
| November 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| November 23, 2021 |
Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter TORONTO, Nov. |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-38403 CUSIP: 22717L1013 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| August 6, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 6, 2021 |
Letter Agreement, dated as of August 6, 2021, between Hortican, Cronos Group and Jerry Barbato Exhibit 10.4 EXECUTION VERSION August 6, 2021 Jerry Barbato At the Address on file with the Company Dear Jerry, This letter agreement (this ?Letter Agreement?), effective as of August 9, 2021 (the ?Effective Date?), sets forth the terms and conditions of our agreement regarding the separation of your employment with Hortican Inc., a corporation organized under the federal laws of Canada (the ?Comp |
|
| August 6, 2021 |
Exhibit 10.3 EXECUTION VERSION EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - ROBERT MADORE (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in th |
|
| August 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 6, 2021 |
Exhibit 99.1 Cronos Group Reports 2021 Second Quarter Results Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach? launched new products in the edible, concentrate, and flower categories in Canada TORONTO, August 6, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (? |
|
| August 6, 2021 |
Exhibit 10.2 AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - TODD ABRAHAM (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) and solely for the purposes specified herein, HORTICAN INC. (?Hortican?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Grou |
|
| June 25, 2021 |
Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders Exhibit 99.1 Cronos Group Inc. Announces Results of 2021 Annual Meeting of Shareholders TORONTO, June 25, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group? or the ?Company?) announces that at its Annual Meeting of Shareholders held earlier today (the ?Meeting?) there were 430 shareholders voting in person or by proxy holding in total 280,023,803 common shares of the Company, repr |
|
| June 25, 2021 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 15, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 15, 2021 |
Exhibit 2.1 EXECUTION VERSION Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. OPTION PURCHASE AGREEMENT BY AND AMONG PHARMACANN INC., A DELAWARE CORPORATION, CRONOS USA HOLDINGS INC., A DELAWARE CORPORATION and upon execution of a joinder hereto, SUCH ADDITIONAL PURCHASERS Date |
|
| June 15, 2021 |
Exhibit 2.2 EXECUTION VERSION THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?ACT?), OR THE SECURITIES LAWS OF ANY STATE. THE SECURITIES REPRESENTED HEREBY HAVE BEEN TAKEN BY THE REGISTERED OWNER FOR INVESTMENT, AND WITHOUT A VIEW TO RESALE OR DISTRIBUTION THEREOF, AND MAY NOT BE SOLD, TRANSFERRED OR DISPOSED OF EXCEPT PURSUANT TO AN EF |
|
| June 14, 2021 |
Exhibit 99.1 Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and Northeast TORONTO and CHICAGO, June 14, 2021 ? Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group?) and |
|
| June 14, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 4, 2021 |
Exhibit 99.1 Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO ? June 4, 2021 ? Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (?Cronos Group?), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (?Ginkgo?), which is building the leading horizontal platform |
|
| June 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer |
|
| June 4, 2021 |
Exhibit 10.1 Certain information, identified by brackets, has been excluded from the Amended and Restated Collaboration and License Agreement because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENT between GINKGO BIOWORKS, INC. and CRONOS GROUP INC. TABLE OF CONTENTS Page 1. DEFINITIONS 5 2. COLLABO |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 111 Peter Street, Suite 300 Toronto, Ontario M5V 2H1 (Address of |
|
| June 1, 2021 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2020 Overview: Cronos Group Inc. is an innovative global cannabinoid company with international production and distribution across five continents. References to ?Cronos? in this report refer to Cronos Group Inc. and its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and in |
|
| May 7, 2021 |
Exhibit 99.1 Cronos Group Reports 2021 First Quarter Results Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans to launch Spinach? branded edibles to the Canadian adult-use market Launches transformative Lord Jones? brand campaign entitled, "A Higher Order" Cronos Israel expands PEACE NATURALS? brand into the pre-roll category in t |
|
| May 7, 2021 |
EX-10.1 2 ex101.htm EX-10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: HORTICAN INC. (the “Company”) - and - TODD ABRAHAM (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company, through one or more of its wholly-owned subsidiaries, is in |
|
| May 7, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer o |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| May 7, 2021 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT (this ?Agreement?) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the ?Company?) - and - ANNA SHLIMAK (the ?Executive?) - and ? solely for the purposes specified herein, CRONOS GROUP INC. (?Cronos Group?) WHEREAS the Company is a wholly-owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in a senior and speciali |
|
| April 27, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| April 27, 2021 |
DEFA14A 1 noticeofinternet2021.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only |
|
| February 26, 2021 |
List of Subsidiaries of Cronos Group Inc. Exhibit 21.1 SUBSIDIARIES OF CRONOS GROUP INC. As of December 31, 2020 Subsidiaries State or other jurisdiction of incorporation or organization Hortican Inc. Canada Peace Naturals Project Inc. Canada Cronos Global Holdings Inc. Canada Cronos Canada Holdings Inc. Canada Original BC Ltd. Canada Cronos Malta Holdings Limited Malta Cronos Research Labs Ltd. Israel Cronos Israel G.S. Store Ltd. Israel |
|
| February 26, 2021 |
Cronos Group Inc. Code of Business Conduct and Ethics EX-14.1 3 a1411.htm EX-14.1 Exhibit 14.1 Code of Business Conduct and Ethics Cronos Group Inc. Effective as of November 1, 2018 Department: Legal Policy Owner: Xiuming Shum, General Counsel Policy Validator: Board of Directors of Cronos Group Inc. For updates or additions, please contact the Legal Department at [email protected] This document is uncontrolled when printed. For |
|
| February 26, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2021 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| February 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP INC. (Exact na |
|
| February 26, 2021 |
Description of Capital Stock of Cronos Group Inc. Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following description of the capital stock of Cronos Group Inc. (the ?Company,? ?we,? ?us,? and ?our?) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Continuation, Notice of Articles and Articles (the ?Art |
|
| February 26, 2021 |
Exhibit 99.1 Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the Israeli medical cannabis market Preserves robust balance sheet with approximately USD$1.3 billion in cash and short-term investments TORONTO, February 26, 2021 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRO |
|
| November 5, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Emplo |
|
| November 5, 2020 |
Exhibit 99.1 Cronos Group Reports 2020 Third Quarter Results Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance™, in the U.S. market in partnership with Kristen Bell Cronos Israel received approval to sell PEACE NATURALS™ branded pre-rolls and oils in Israel Cronos Device Labs expands its cannabinoid research sc |
|
| November 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS |
|
| September 9, 2020 |
Exhibit 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT B E T W E E N: CRONOS USA CLIENT SERVICES LLC a limited liability company incorporated in the State of Delaware (hereinafter referred to as the “Company”) -and- MICHAEL GORENSTEIN, an individual resident in Miami Beach, in the State of Florida (hereinafter referred to as the “Executive”) -and- CRONOS GROUP INC., a corporation incorporated in B |
|
| September 9, 2020 |
Exhibit 99.1 Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO, September 9, 2020 – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that its Board of Directors has appointed Kurt Schmidt Presi |
|
| September 9, 2020 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) BETWEEN: CRONOS USA CLIENT SERVICES LLC (the “Company”) - and - KURT SCHMIDT (the “Executive”) - and – solely for the purposes specified herein, CRONOS GROUP INC. (“Cronos Group”) WHEREAS the Company is a wholly owned subsidiary of Cronos Group; WHEREAS the Company wishes to engage the services of the Executive in the position of Presi |
|
| September 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Empl |
|
| August 6, 2020 |
Exhibit 10.1 CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN ARTICLE I GENERAL 1.1 Purpose The purpose of the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”) is to help Cronos Group Inc., a corporation formed under the Business Corporations Act (Ontario) (“Cronos”): (1) attract, retain and motivate key employees (including prospective employees) |
|
| August 6, 2020 |
Exhibit 99.1 Cronos Group Reports 2020 Second Quarter Results Cronos Israel commenced the sale of PEACE NATURALSTM products to the Israeli medical cannabis market Natuera completed three additional test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes Successfully implemented a new enterprise resource planning system across our Canadian business Appointed n |
|
| August 6, 2020 |
Exhibit 3.1 Number: C1256453 CERTIFICATE OF CONTINUATION BUSINESS CORPORATIONS ACT I Hereby Certify that Cronos Group Inc., has continued into British Columbia from the Jurisdiction of ONTARIO, under the Business Corporations Act, with the name CRONOS GROUP INC. on July 9, 2020 at 01:15 PM Pacific Time. ELECTRONIC CERTIFICATE This Notice of Articles was issued by the Registrar on: July 9, 2020 01: |
|
| August 6, 2020 |
Exhibit 10.3 FORM OF CRONOS GROUP INC. RESTRICTED SHARE UNIT AWARD AGREEMENT (Applicable for Israeli Grantees) This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this day of , 20 (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the C |
|
| August 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROUP |
|
| August 6, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employe |
|
| August 6, 2020 |
Exhibit 10.2 FORM OF CRONOS GROUP INC. RESTRICTED SHARE UNIT AGREEMENT This Restricted Share Unit Award Agreement (hereinafter referred to as the “Agreement”) is made and entered into this day of , 20 (the “Grant Date”) by and between Cronos Group Inc. (hereinafter referred to as “Cronos”) and [●] (hereinafter referred to as the “Grantee”), pursuant to the Cronos Group Inc. 2020 Omnibus Equity Inc |
|
| July 20, 2020 |
Exhibit 10.1 EXECUTION VERSION CONFIDENTIAL July 20, 2020 Robert Rosenheck At the Address on file with the Company Dear Rob, This letter agreement (this “Letter Agreement”), effective as of the date hereof (the “Effective Date”), sets forth the terms and conditions of your resignation of employment from Redwood Wellness, LLC, a Delaware limited liability company (the “Company”). Capitalized terms |
|
| July 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incor |
|
| July 9, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incorp |
|
| July 9, 2020 |
Cronos Group Announces Completion of Continuance to British Columbia Exhibit 99.1 Cronos Group Announces Completion of Continuance to British Columbia TORONTO, July 9, 2020 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that, effective today, the Company has continued from the laws of the Province of Ontario to the laws of the Province of British Columbia (the “Continuance”).The Continuance was approved by shareholders of |
|
| June 25, 2020 |
Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders Exhibit 99.1 Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders TORONTO, June 25, 2020 - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual and Special Meeting of Shareholders held earlier today (the “Meeting”) there were 652 shareholders voting in person or by proxy holding in total 195,124,634 common sha |
|
| June 25, 2020 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2020 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction (Commission (I.R.S. Employer of incor |
|
| June 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report CRONOS GROUP INC. (Exact name of the registrant as specified in its charter) Ontario, Canada 001-38403 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 720 King St. W., Suite 320 Toronto, Ontario M5V 2T3 (Address of principal |
|
| June 1, 2020 |
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD. Exhibit 1.01 CRONOS GROUP INC. CONFLICT MINERALS REPORT FOR THE YEAR ENDED DECEMBER 31, 2019 Overview: Cronos Group Inc. is an innovative global cannabinoid company with international production and distribution across five continents. References to “Cronos” in this report refer to Cronos Group Inc. and its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and in |
|
| May 8, 2020 |
EXHIBIT 99.1 Cronos Group Reports 2020 First Quarter Results Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel, as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS™ branded products Natuera completes key operational milestones and begins test exports to the |
|
| May 8, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2020 CRONOS GROUP INC. (Exact Name of Registrant as Specified in Charter) Ontario, Canada 001-38403 N/A (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 001-38403 CRONOS GROU |
|
| April 28, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| April 6, 2020 |
CRON / Cronos Group Inc. PRE 14A - - PRE 14A PRE 14A 1 prelimproxystatement.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of t |
|
| April 1, 2020 |
Cronos Group Inc. 2020 Omnibus Equity Incentive Plan. Exhibit 99.1 CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN CRONOS GROUP INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN ARTICLE I GENERAL 1.1 Purpose The purpose of the Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (as amended from time to time, the “Plan”) is to help Cronos Group Inc., a corporation formed under the Business Corporations Act (Ontario) (“Cronos”): (1) attract, retain and mot |
|
| April 1, 2020 |
CRON / Cronos Group Inc. S-8 - - S-8 As filed with the U.S. Securities and Exchange Commission on April 1, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CRONOS GROUP INC. (Exact name of registrant as specified in its charter) Ontario, Canada N/A (State or other jurisdiction of incorporation or organization) (IRS Employe |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A ' UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) I |
|
| March 30, 2020 |
Exhibit 99.2 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Six Months Ended June 30, 2019 (in thousands of Canadian dollars) 1 Notice to reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019 |
|
| March 30, 2020 |
Exhibit 99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended June 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim fi |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Condensed Interim Unaudited Consolidated Financial Statements For the Three Months Ended March 31, 2019 and March 31, 2018 (In thousands of Canadian dollars) Notice to Reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six mont |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) Ind |
|
| March 30, 2020 |
Notice to Reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six months ended June 30, 2019, and the three and nine months ended September 30, 2019, which were previously filed on SEDAR (the “interim financial statements”). Subsequent to the original issuance of the |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended June 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim fi |
|
| March 30, 2020 |
Exhibit 99.4 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three Months Ended March 31, 2019 (in thousands of Canadian dollars) 1 NOTICE TO READER Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the s |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended March 31, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the interim f |
|
| March 30, 2020 |
CRON / Cronos Group Inc. 6-K/A - Current Report of Foreign Issuer - 6-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K/A Report of Foreign Private Issuer Pursuant to Section 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of March 2020 Commission File No. 001-38403 CRONOS GROUP INC. (Name of registrant) 720 King Street W., Suite 320 Toronto, Ontario M5V 2T3 (Address of registrant’s principal executive office) Ind |
|
| March 30, 2020 |
Exhibit 99.1 Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids in partnership with Ginkg |
|
| March 30, 2020 |
CRONOS GROUP INC. Amended and Restated Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three and Nine Months Ended September 30, 2019 (in thousands of Canadian dollars) 1 Notice to reader Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31 |
|
| March 30, 2020 |
Exhibit 99.3 NOTICE TO READER As of June 30, 2019, Cronos Group Inc. (the “Company”) determined that it no longer qualified as a “foreign private issuer” as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchan |
|
| March 30, 2020 |
Exhibit 99.3 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended September 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the inter |
|
| March 30, 2020 |
The following items were the subject of a Form 12b-25 and are included herein: Items 6, 7, 7A, 8, 9A, 9B and Exhibits 23. |
|
| March 30, 2020 |
Exhibit 99.4 FORM 52-109F2R CERTIFICATION OF REFILED INTERIM FILINGS This certificate is being filed on the same date that Cronos Group Inc. (the “issuer”) has refiled the interim financial report and related MD&A for the interim period ended September 30, 2019 by filing (i) an amended and restated interim financial report, (ii) a restated interim financial report (each of (i) and (ii), “the inter |
